ID: MRFR/HCIT/1522-HCR | 90 Pages | Author: Kinjoll Dey | November 2023
Table of Contents:
Chapter 1. Executive Summary
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porterβs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 R&D and Designing
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-Sales Review
Chapter 6. Global Clinical Trial Management Market, by Type
6.1 Overview
6.2 Enterprise CTMS
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.3 On-Site CTMS
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
Chapter 7. Global Clinical Trial Management Market, by Delivery Model
7.1 Overview
7.2 Web-Based (Hosted CTMS)
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7.3 Licensed Enterprise
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7.4 Cloud-Based CTMS (SaaS)
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
Chapter 8. Global Clinical Trial Management Market, by Component
8.1 Overview
8.2 Software
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8.3 Service
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8.4 Hardware
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
Chapter 9. Global Clinical Trial Management Market, by End User
9.1 Overview
9.2 Pharmaceutical and Biopharmaceutical Companies
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
9.3 Medical Device Manufacturers
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
9.4 Contract Research Organizations
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
9.5 Others
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
Chapter 10. Global Clinical Trial Management Market, by Region
10.1 Overview
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11. Company Landscape
11.1 Overview
11.2 Competitive Analysis
Chapter 12. Company Profile
12.1 Forte Research Systems Inc.
12.1.1 Company Overview
12.1.2 Products/Services Offered
12.1.3 Financial Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 eClinForce, Inc.
12.2.1 Company Overview
12.2.2 Products/Services Offered
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategies
12.3 Oracle
12.3.1 Company Overview
12.3.2 Products/Services Offered
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.3.6 Key Strategies
12.4 Medidata Solutions
12.4.1 Company Overview
12.4.2 Products/Services Offered
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.4.6 Key Strategies
12.5 iWeb Technologies
12.5.1 Company Overview
12.5.2 Products/Services Offered
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategies
12.6 PAREXEL
12.6.1 Company Overview
12.6.2 Products/Services Offered
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategies
12.7 Bioclinica
12.7.1 Overview
12.7.2 Products/Services Offered
12.7.3 Financial Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategies
12.8 Bio-Optronics
12.8.1 Overview
12.8.2 Products/Services Offered
12.8.3 Financial Overview
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategies
12.9 IBM
12.9.1 Overview
12.9.2 Products/Services Offered
12.9.3 Financial Overview
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategies
12.10 Datatrak
12.10.1 Overview
12.10.2 Products/Services Offered
12.10.3 Financial Overview
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategies
12.11 Veeva Systems
12.11.1 Overview
12.11.2 Products/Services Offered
12.11.3 Financial Overview
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategies
12.12 DSG
12.12.1 Overview
12.12.2 Products/Services Offered
12.12.3 Financial Overview
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12.6 Key Strategies
12.13 Mastercontrol
12.13.1 Overview
12.13.2 Products/Services Offered
12.13.3 Financial Overview
12.13.4 Key Developments
12.13.5 SWOT Analysis
12.13.6 Key Strategies
12.14 ERT
12.14.1 Overview
12.14.2 Products/Services Offered
12.14.3 Financial Overview
12.14.4 Key Developments
12.14.5 SWOT Analysis
12.14.6 Key Strategies
12.15 Mednet Solutions
12.15.1 Overview
12.15.2 Products/Services Offered
12.15.3 Financial Overview
12.15.4 Key Developments
12.15.5 SWOT Analysis
12.15.6 Key Strategies
12.16 Arisglobal
12.16.1 Overview
12.16.2 Products/Services Offered
12.16.3 Financial Overview
12.16.4 Key Developments
12.16.5 SWOT Analysis
12.16.6 Key Strategies
12.17 DZS Software Solutions
12.17.1 Overview
12.17.2 Products/Services Offered
12.17.3 Financial Overview
12.17.4 Key Developments
12.17.5 SWOT Analysis
12.17.6 Key Strategies
12.18 Others
Chapter 13 Appendix
13.1 References
13.2 Related Reports
LIST OF TABLES
Table 1 Global Clinical Trial Management Market Synopsis, 2020β2027
Table 2 Global Clinical Trial Management Market Estimates and Forecast, 2020β2027 (USD Million)
Table 3 Global Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 4 Global Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 5 Global Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 6 Global Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 7 Global Clinical Trial Management Market, by Region, 2020β2027 (USD Million)
Table 8 Americas: Clinical Trial Management Market, by Region, 2020 and 2027
Table 9 Americas: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 10 Americas: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 11 Americas: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 12 Americas: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 13 North America: Clinical Trial Management Market, by Country, 2020β2027 (USD Million)
Table 14 North America: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 15 North America: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 16 North America: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 17 North America: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 18 US: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 19 US: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 20 US: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 21 US: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 22 Canada: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 23 Canada: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 24 Canada: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 25 Canada: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 26 Latin America: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 27 Latin America: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 28 Latin America: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 29 Latin America: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 30 Europe: Clinical Trial Management Market, by Region, 2020β2027 (USD Million)
Table 31 Europe: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 32 Europe: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 33 Europe: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 34 Europe: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 35 Western Europe: Clinical Trial Management Market, by Country, 2020β2027 (USD Million)
Table 36 Western Europe: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 37 Western Europe: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 38 Western Europe: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 39 Western Europe: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 40 Eastern Europe: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 41 Eastern Europe: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 42 Eastern Europe: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 43 Eastern Europe: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 44 Asia-Pacific: Clinical Trial Management Market, by Country, 2020β2027 (USD Million)
Table 45 Asia-Pacific: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 46 Asia-Pacific: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 47 Asia-Pacific: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 48 Asia-Pacific: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
Table 49 Middle East & Africa: Clinical Trial Management Market, by Region, 2020β2027 (USD Million)
Table 50 Middle East & Africa: Clinical Trial Management Market, by Type, 2020β2027 (USD Million)
Table 51 Middle East & Africa: Clinical Trial Management Market, by Delivery Model, 2020β2027 (USD Million)
Table 52 Middle East & Africa: Clinical Trial Management Market, by Component, 2020β2027 (USD Million)
Table 53 Middle East & Africa: Clinical Trial Management Market, by End User, 2020β2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Market Structure for Global Clinical Trial Management Market
Figure 3 Market Dynamics for Global Clinical Trial Management Market
Figure 4 Global Clinical Trial Management Market Share, by Type, 2020 (%)
Figure 5 Global Clinical Trial Management Market Share, by Type, 2020 (USD Million)
Figure 6 Global Clinical Trial Management Market Share, by Delivery Model, 2020 (%)
Figure 7 Global Clinical Trial Management Market Share, by Delivery Model, 2020 (USD Million)
Figure 8 Global Clinical Trial Management Market Share, by Component, 2020 (%)
Figure 9 Global Clinical Trial Management Market Share, by Component, 2020 (USD Million)
Figure 10 Global Clinical Trial Management Market Share, by End User, 2020 (%)
Figure 11 Global Clinical Trial Management Market Share, by End User, 2020 (USD Million)
Figure 12 Global Clinical Trial Management Market Share, by Region, 2020 (%)
Figure 13 Americas: Clinical Trial Management Market Share, by Region, 2020 (%)
Figure 14 North America: Clinical Trial Management Market Share, by Country, 2020 (%)
Figure 15 Europe: Clinical Trial Management Market Share, by Region, 2020 (%)
Figure 16 Western Europe: Clinical Trial Management Market Share, by Country, 2020 (%)
Figure 17 Asia-Pacific: Clinical Trial Management Market Share, by Country, 2020 (%)
Figure 18 Middle East & Africa: Clinical Trial Management Market Share, by Region, 2020 (%)
Figure 19 Global Clinical Trial Management Market: Company Share Analysis, 2020 (%)
Figure 20 Forte Research Systems Inc.: Key Financials
Figure 21 Forte Research Systems Inc.: Segmental Revenue
Figure 22 Forte Research Systems Inc.: Geographical Revenue
Figure 23 eClinForce, Inc.: Key Financials
Figure 24 eClinForce, Inc.: Segmental Revenue
Figure 25 eClinForce, Inc.: Geographical Revenue
Figure 26 Oracle: Key Financials
Figure 27 Oracle: Segmental Revenue
Figure 28 Oracle: Geographical Revenue
Figure 29 Medidata Solutions: Key Financials
Figure 30 Medidata Solutions: Segmental Revenue
Figure 31 Medidata Solutions: Geographical Revenue
Figure 32 iWeb Technologies: Key Financials
Figure 33 iWeb Technologies: Segmental Revenue
Figure 34 iWeb Technologies: Geographical Revenue
Figure 35 PAREXEL: Key Financials
Figure 36 PAREXEL: Segmental Revenue
Figure 37 PAREXEL: Geographical Revenue
Figure 38 Bioclinica: Key Financials
Figure 39 Bioclinica: Segmental Revenue
Figure 40 Bioclinica: Geographical Revenue
Figure 41 Bio-Optronics: Key Financials
Figure 42 Bio-Optronics: Segmental Revenue
Figure 43 Bio-Optronics: Geographical Revenue
Figure 44 IBM: Key Financials
Figure 45 IBM: Segmental Revenue
Figure 46 IBM: Geographical Revenue
Figure 47 Datatrak: Key Financials
Figure 48 Datatrak: Segmental Revenue
Figure 49 Datatrak: Geographical Revenue
Figure 50 Veeva Systems: Key Financials
Figure 51 Veeva Systems: Segmental Revenue
Figure 52 Veeva Systems: Geographical Revenue
Figure 53 DSG: Key Financials
Figure 54 DSG: Segmental Revenue
Figure 55 DSG: Geographical Revenue
Figure 56 Mastercontrol: Key Financials
Figure 57 Mastercontrol: Segmental Revenue
Figure 58 Mastercontrol: Geographical Revenue
Figure 59 ERT: Key Financials
Figure 60 ERT: Segmental Revenue
Figure 61 ERT: Geographical Revenue
Figure 62 Mednet Solutions: Key Financials
Figure 63 Mednet Solutions: Segmental Revenue
Figure 64 Mednet Solutions: Geographical Revenue
Figure 65 Arisglobal: Key Financials
Figure 66 Arisglobal: Segmental Revenue
Figure 67 Arisglobal: Geographical Revenue
Figure 68 DZS Software Solutions: Key Financials
Figure 69 DZS Software Solutions: Segmental Revenue
Figure 70 DZS Software Solutions: Geographical Revenue
Market Segmentation Tab for Clinical Trial Management System Market
Clinical Trial Management System Type Outlook (USD Billion, 2018-2030)
Clinical Trial Management System Delivery Model Outlook (USD Billion, 2018-2030)
Clinical Trial Management System Β Component Outlook (USD Billion, 2018-2030)
Clinical Trial Management System Β End User Outlook (USD Billion, 2018-2030)
Clinical Trial Management System Regional Outlook (USD Billion, 2018-2030)
Β
Research Methodology on Clinical Trial Management System Market
The research methodology applied in this study is an in-depth exploration of the global Clinical Trial Management System (CTMS) Market. The research report offers an extensive analysis of the market, encompassing Porterβs Five Forces analysis, PESTEL analysis, value chain analysis, and SWOT analysis. In addition, the report examines the market revenue and volume, drivers, trends, challenges, and opportunities.
Primary Research
The primary research includes in-depth interviews and discussions with technology vendors and industry experts.
Secondary Research
For conducting the research study, secondary research sources are used such as industry journals, white papers, market reports, industry magazines, and paid databases. Details such as market size, forecast, categories and segments, market structure, market dynamics, and competitive insights of the study are collected from various internal and external secondary sources.
Forecast Model
The forecast is based on a detailed review of the strong statistical models used for the research study, combined with information and insights elicited from secondary sources and primary research. The forecast model uses factors such as market dynamics and trends, market segments, and development plans of the leading players to provide an accurate measure of the market.
Market Development
Market development involves the positioning marketβs size and its share development in different countries. It focuses on the growth of the primary players in the market and the impact of their strategies on the growth of the global CTMS market.
Market Estimation Techniques
The research uses several techniques for the estimation of the market size. These techniques include bottom-up and top-down approaches. The top-down approach is mostly preferred for the estimation of the global size of the market. In this approach, the market share of the key players operating in the market is used to arrive at an estimation of the total size of the market. The bottom-up approach is extensively used for the estimation of the number of primary players operating in the market.
Data Triangulation
To validate the study findings, market information is triangulated with different techniques such as investment analysis, and the use of various financial synthesis techniques. Thus, the data collected from several sources is triangulated to arrive at an accurate estimate of the global Clinical Trial Management System market.
Scope of the Report
This report offers an in-depth analysis of the global CTMS market. The scope of the report includes an overview of the market and estimates for the period 2023β2030. It provides a detailed assessment of all the key segments in the market and provides market value, drivers, trends, challenges, and opportunities. The report also provides a detailed analysis of the market drivers, trends, market dynamics, and competitive landscape of the global market for CTMS.